Intraocular bevacizumab for iris neovascularization in a silicone oil-filled eye.
To report the effectiveness of intravitreal injection of bevacizumab for treatment of iris neovascularization in a silicone oil-filled eye. Case report. A 56-year-old man with recurrent retinal detachment associated with iris neovascularization. Iris neovascularization regressed after treatment with a 1.25-mg intravitreal injection of bevacizumab in the presence of silicone oil. Intraocular injection of bevacizumab is an effective short-term treatment of neovascularization caused by persistent retinal detachment even in the presence of silicone oil. The standard dose of 1.25 mg of bevacizumab may not require adjustment in an aphakic vitrectomized eye.